<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03447717</url>
  </required_header>
  <id_info>
    <org_study_id>2126/2016</org_study_id>
    <nct_id>NCT03447717</nct_id>
  </id_info>
  <brief_title>Implanted Drop Foot Stimulator for Hemiparetic Patients</brief_title>
  <official_title>The Long-term Effects of an Implantable Drop Foot Stimulator on Gait in Hemiparetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effects of the implantable drop foot stimulator&#xD;
      &quot;ActiGait&quot; (Ottobock Health Care, Duderstadt, Germany) on gait in hemiparetic patients. While&#xD;
      several studies investigated the effects of implanted systems on walking speed and gait&#xD;
      endurance, only a few studies have focused on the system's impact on kinematics and long-term&#xD;
      outcomes. Therefore, our aim was to further investigate the effects of the implanted system&#xD;
      ActiGait on gait kinematics and spatiotemporal parameters with a 1-year follow-up period.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with a neurologic condition leading to drop foot during swing phase in gait are&#xD;
      treated by the implentation of the AcitGait system (which has a CE-certificate in Europe).&#xD;
&#xD;
      The aim of this study is to investigate the effect of the device on gait with a follow-up&#xD;
      period of one year. Patients are assessed before implantation and at one-year follow up. At&#xD;
      baseline, they are asked to walk without any assistive device, as well as with surface&#xD;
      electrical stimulation of the peroneal nerve. At follow-up, they are asked to walk with the&#xD;
      ActiGait system switched off and switched on.&#xD;
&#xD;
      Outcome assessments include a 10m-walking test and gait analysis with a VICON 3D-camera&#xD;
      system. This allows to extract spatio-temporal parameters (as steps per minute, step&#xD;
      length,...) as well as kinematic data (e.g. joint ankles during the gait cycle). All outcome&#xD;
      data is analyzed using statistical tests.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 26, 2012</start_date>
  <completion_date type="Actual">February 29, 2016</completion_date>
  <primary_completion_date type="Actual">February 29, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>patients meeting the inclusion criteria are included</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>kinematic gait parameters</measure>
    <time_frame>1 year</time_frame>
    <description>Kinematic gait parameters are recorded and analysed using a 3D VICON infra-red camera system.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>spatio-temporal parameters</measure>
    <time_frame>1 year</time_frame>
    <description>Spatio-temproal parameters are recorded and analysed using a 3D VICON infra-red camera system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>10-m-walking test</measure>
    <time_frame>1 year</time_frame>
    <description>The 10-m-walking test is a standardised clinical test where the patient is asked to walk for 10m at the fastest convenient walking speed and time is taken.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale for Health</measure>
    <time_frame>1 year</time_frame>
    <description>Using a 100mm Visual Analogue Scale (VAS) patients are asked to mark their current health status between 0 (worst possible health) and 100 (best possible health).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Gait, Hemiplegic</condition>
  <arm_group>
    <arm_group_label>ActiGait</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who get the ActiGait implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ActiGait</intervention_name>
    <description>implanted device for peroneal nerve stimulation</description>
    <arm_group_label>ActiGait</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  drop foot after stroke, brain haemorrhage or multiple sclerosis&#xD;
&#xD;
          -  a minimum of six months after the acute infarction/onset of the disease&#xD;
&#xD;
          -  passive extension of the ankle to at least at neutral position&#xD;
&#xD;
          -  no sufficient active ankle extension&#xD;
&#xD;
          -  free walking without any aid for at least 20 meters in less than 2 minutes&#xD;
&#xD;
          -  a walking speed of â‰¤ 1,2m/sec (measured with 10 meter walking test)&#xD;
&#xD;
          -  use of surface electrical stimulation for at least three months&#xD;
&#xD;
          -  be able to stand freely&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  damage to the peripheral nervous system&#xD;
&#xD;
          -  epilepsy&#xD;
&#xD;
          -  adiposity&#xD;
&#xD;
          -  substance abuse&#xD;
&#xD;
          -  no cognitive ability to follow the study instructions&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  use of other implanted devices&#xD;
&#xD;
          -  instable ankle joint or fixed contracture&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oskar C Aszmann, MD</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>February 21, 2018</study_first_submitted>
  <study_first_submitted_qc>February 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Agnes Sturma</investigator_full_name>
    <investigator_title>Physitherapist, Researcher</investigator_title>
  </responsible_party>
  <keyword>hemiplegic gait</keyword>
  <keyword>peroneal nerve stimulation</keyword>
  <keyword>gait analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gait Disorders, Neurologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD from the mentioned outcome parameters are planned to be made available to other researchers.</ipd_description>
    <ipd_time_frame>upon publication in a scientific journal</ipd_time_frame>
    <ipd_access_criteria>publically available</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

